V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20223303 | 20084667 | 1.68 | 67 | Adjuvant (A) | 2016-09-06 | 2016-09-06 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100985297 |
| 20223304 | 20084668 | 0 | 101 | Palliative (P) | 2017-11-12 | 2017-11-15 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100382479 |
| 20223311 | 20084669 | 1.72 | 85.4 | Adjuvant (A) | 2017-04-29 | 2017-04-29 | Enzalutamide | 02 | N | CETUXIMAB | 101301668 |
| 20223313 | 20084670 | 1.68 | 101.2 | Palliative (P) | 2019-02-25 | 2019-02-25 | Enzalutamide | null | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100425188 |
| 20223316 | 20084671 | 1.69 | 63.7 | null | 2018-08-13 | 2018-08-24 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101372044 |
| 20223317 | 20084672 | 0 | 0 | 03 | 2016-10-10 | 2016-10-14 | Cisplatin | 02 | N | CETUXIMAB | 101230959 |
| 20223328 | 20084673 | 1.67 | 85.2 | Curative (C) | 2016-08-20 | 2016-09-03 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 100679669 |
| 20223331 | 20084674 | 1.74 | null | Palliative (P) | 2018-05-14 | 2018-05-14 | Enzalutamide | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101475893 |
| 20223341 | 20084675 | 1.78 | 75.6 | Palliative (P) | 2018-11-17 | 2018-11-17 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101557991 |
| 20223342 | 20084676 | 1.7 | 61.5 | Palliative (P) | 2017-01-25 | 2017-01-25 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101132155 |
| 20223351 | 20084677 | 1.71 | 135.5 | null | 2021-04-25 | 2021-04-25 | OCTREOTIDE | 02 | null | ECF | 100344915 |
| 20223359 | 20084678 | 1.65 | 80.6 | Palliative (P) | 2021-11-12 | 2021-11-12 | Enzalutamide | null | N | CARBOPLATIN + GEMCITABINE | 101719266 |
| 20223361 | 20084679 | 1.78 | 55 | null | 2017-10-20 | 2017-10-24 | Enzalutamide | 02 | null | SCALOP-2 TRIAL | 101595573 |
| 20223373 | 20084680 | 1.79 | 67 | null | 2019-06-27 | 2019-06-27 | Enzalutamide | N | null | CETUXIMAB | 101775631 |
| 20223375 | 20084681 | 1.6 | 61.7 | Neo-adjuvant (N) | 2019-05-26 | 2019-05-26 | Enzalutamide | 02 | N | CISPLATIN | 100824427 |
| 20223376 | 20084682 | 1.86 | 79.75 | Palliative (P) | 2019-04-02 | 2019-04-02 | Enzalutamide | 02 | N | CISPLATIN | 101568626 |
| 20223377 | 20084683 | 1.64 | 59.4 | null | 2018-07-11 | 2018-08-04 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101720190 |
| 20223384 | 20084684 | 1.69 | 93.9 | null | 2017-01-10 | 2017-01-10 | Enzalutamide | 2 | null | LUTETIUM-177 | 100626986 |
| 20223386 | 20084685 | 1.7 | 71 | Palliative (P) | 2019-05-13 | 2019-05-13 | Enzalutamide | 02 | N | CISPLATIN | 101001103 |
| 20223410 | 20084686 | 1.74 | 95.1 | Palliative (P) | 2017-04-11 | 2017-04-13 | Enzalutamide | 02 | N | CARBOPLATIN | 100797935 |
| 20223411 | 20084687 | 1.61 | 140.3 | Palliative (P) | null | 2018-07-01 | Enzalutamide | 02 | N | CISPLATIN | 100851875 |
| 20223412 | 20084688 | 1.75 | 84 | Curative (C) | 2016-07-27 | 2016-08-04 | Enzalutamide | 02 | Y | CARBOPLATIN | 101451890 |
| 20223418 | 20084689 | 1.77 | 70.3 | Curative (C) | 2019-01-07 | 2019-01-20 | Enzalutamide | 02 | Y | MITOMYCIN INTRAVESICULAR | 101627396 |
| 20223425 | 20084690 | 1.7 | 77.2 | Palliative (P) | 2018-06-02 | 2018-06-23 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | CARBOPLATIN + PACLITAXEL + RT | 100388047 |
| 20223428 | 20084691 | 1.55 | 87 | Neo-adjuvant (N) | 2016-11-04 | 2016-11-04 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100229232 |
| 20223430 | 20084692 | null | 67.3 | null | 2017-12-25 | 2018-01-01 | Enzalutamide | null | null | SCALOP-2 TRIAL | 101818952 |
| 20223435 | 20084693 | 1.62 | 104 | Adjuvant (A) | 2016-11-09 | 2016-11-20 | CARBOPLATIN + PACLITAXEL + RT | N | Y | CARBOPLATIN + PACLITAXEL + RT | 101563564 |
| 20223446 | 20084694 | 1.78 | null | 03 | 2018-06-09 | 2018-06-11 | Capecitabine + Cisplatin + RT | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100321704 |
| 20223450 | 20084695 | 1.56 | 60.8 | Neo-adjuvant (N) | 2016-03-01 | 2016-03-02 | Enzalutamide | 02 | N | CETUXIMAB | 100801712 |
| 20223453 | 20084696 | 1.66 | 66.5 | Neo-adjuvant (N) | 2016-11-13 | 2016-11-13 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101140907 |
| 20223459 | 20084697 | 1.75 | 94.6 | Palliative (P) | null | 2016-11-02 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101658914 |
| 20223463 | 20084698 | null | 0 | Curative (C) | 2017-02-02 | 2017-02-03 | Enzalutamide | 02 | N | CARBOPLATIN | 100218749 |
| 20223469 | 20084699 | 1.7 | 67.5 | Curative (C) | 2017-01-21 | 2017-01-29 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100680986 |
| 20223475 | 20084700 | 1.59 | 71.1 | 03 | 2017-02-13 | 2017-02-26 | Enzalutamide | 02 | N | CARBOPLATIN | 100379248 |
| 20223476 | 20084701 | 1.6 | 66 | null | 2016-11-14 | 2016-11-14 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100177400 |
| 20223477 | 20084702 | 1.79 | 75.4 | Palliative (P) | 2016-02-26 | 2016-03-03 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100121290 |
| 20223478 | 20084703 | 1.55 | 93.8 | Palliative (P) | 2016-07-31 | 2016-08-12 | Enzalutamide | N | N | OCTREOTIDE | 101139357 |
| 20223484 | 20084704 | 1.59 | 51.5 | Curative (C) | 2017-05-02 | 2017-05-02 | Enzalutamide | 02 | Y | ECF | 100006488 |
| 20223488 | 20084705 | 1.74 | 89.4 | null | 2017-07-05 | 2017-07-06 | Enzalutamide | N | null | ATEZOLIZUMAB + BEVACIZUMAB | 100590326 |
| 20223489 | 20084706 | null | 120 | Palliative (P) | 2019-08-04 | 2019-08-20 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100094797 |
| 20223490 | 20084707 | 1.53 | 148.7 | Disease modification (D) | 2017-01-14 | 2017-02-18 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101617241 |
| 20223495 | 20084708 | 1.57 | 69.7 | Palliative (P) | 2019-11-07 | 2019-11-09 | Enzalutamide | null | N | CETUXIMAB + OXALIPLATIN + MDG | 101812736 |
| 20223497 | 20084709 | 0 | 83.2 | Curative (C) | 2018-08-24 | 2018-08-30 | Enzalutamide | 2 | N | ENZALUTAMIDE | 100842167 |
| 20223503 | 20084710 | 1.54 | 78.6 | Neo-adjuvant (N) | 2017-07-27 | 2017-09-05 | OCTREOTIDE | 02 | N | OCTREOTIDE | 100130904 |
| 20223506 | 20084711 | 1.88 | 58.6 | null | 2016-06-20 | 2016-06-22 | Enzalutamide | 02 | N | TRASTUZUMAB | 101749719 |
| 20223508 | 20084712 | 1.8 | 42.25 | null | 2019-09-08 | 2019-11-02 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 101172945 |
| 20223512 | 20084713 | 1.72 | 135.5 | Palliative (P) | 2018-09-27 | 2018-09-27 | Enzalutamide | 2 | N | CARBOPLATIN | 100768129 |
| 20223515 | 20084714 | 1.52 | 63.6 | Palliative (P) | null | 2016-02-28 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 100729210 |
| 20223518 | 20084715 | 1.6 | 58 | Palliative (P) | 2019-11-07 | 2019-12-06 | Enzalutamide | 02 | N | OCTREOTIDE | 100125955 |
| 20223528 | 20084716 | 1.6 | 79 | Palliative (P) | 2019-01-30 | 2019-01-30 | Enzalutamide | 02 | N | CETUXIMAB | 101244940 |